Referred to the House Committee on Energy and Commerce.
Creates a Presidential appointee, the Coordinator of AI Innovation, to coordinate federal use of advanced technologies, including AI, to improve pediatric cancer diagnosis, treatment, and prevention. Directs the Coordinator to identify AI opportunities within the Childhood Cancer Data Initiative, advances interoperability standards for patient data, requires a 180-day report to Congress, and authorizes appropriations including $100 million per year for CCDI AI activities for fiscal years 2027–2031.
Liberal stresses research funding, equity, and bias mitigation.
Relative to its intended legislative type, this bill establishes an administrative coordination mechanism with a clear purpose and some resource authorization, coupled with a short-term reporting requirement.
Creates a Presidential appointee, the Coordinator of AI Innovation, to coordinate federal use of advanced technologies, including AI, to improve pediatric cancer diagnosis, treatment, and prevention.
Directs the Coordinator to identify AI opportunities within the Childhood Cancer Data Initiative, advances interoperability standards for patient data, requires a 180-day report to Congress, and authorizes appropriations including $100 million per year for CCDI AI activities for fiscal years 2027–2031.
Technically focused, bipartisan-leaning policy with clear deliverables increases prospects, though funding authorization and Senate procedure are obstacles.
Relative to its intended legislative type, this bill establishes an administrative coordination mechanism with a clear purpose and some resource authorization, coupled with a short-term reporting requirement. It provides moderate specificity about focus areas but limited operational, governance, and oversight detail.
Liberal stresses research funding, equity, and bias mitigation.
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberal stresses research funding, equity, and bias mitigation.
Generally supportive: advances technology and funding toward pediatric cancer research align with progressive priorities on health equity and science-driven care.
Will want robust privacy, bias mitigation, and explicit measures to ensure underserved communities benefit.
Cautiously favorable: supports targeted coordination and funding to advance pediatric cancer care while seeking clear accountability, measurable outcomes, and cost controls.
Concerned about duplication, unclear authority, and implementation burdens on providers.
Mixed to skeptical: supports helping children with cancer and innovation, but worries about creating new federal bureaucracy and prescriptive interoperability standards.
Seeks limits on federal reach and protections for providers and private sector innovation.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technically focused, bipartisan-leaning policy with clear deliverables increases prospects, though funding authorization and Senate procedure are obstacles.
The bill has not accumulated any surfaced votes yet.
Liberal stresses research funding, equity, and bias mitigation.
Technically focused, bipartisan-leaning policy with clear deliverables increases prospects, though funding authorization and Senate procedu…
Relative to its intended legislative type, this bill establishes an administrative coordination mechanism with a clear purpose and some resource authorization, coupled with a short-term reporting requirement. It provide…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.